2014
DOI: 10.1016/j.jns.2014.03.026
|View full text |Cite
|
Sign up to set email alerts
|

Clinico-pathological factors influencing surgical outcome in drug resistant epilepsy secondary to mesial temporal sclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
8
0
3

Year Published

2015
2015
2024
2024

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(15 citation statements)
references
References 67 publications
4
8
0
3
Order By: Relevance
“…During the short‐term (2‐year) follow‐up, 89% of the patients with type 1 and 85% of those with type 2 had an Engel class I outcome, a higher success rate (only 11–15% outside class I) than that observed in other surgical series, although the outcomes were not as good when considering class Ia in both groups (respectively, 66% and 76%), with no significant difference between them. Differences in recruitment, classification, and outcome scales make it difficult to compare these findings with previously published data, but it can be said that they are similar to those of Blumcke et al., de Lanerolle et al., and Savitr Sastri et al., all of which showed that there is no significant short‐term difference in the percentage of class I outcomes between patients with different HS types, and the studies indicating a difference may have been affected by the small number of patients with type 2 …”
Section: Discussionsupporting
confidence: 52%
“…During the short‐term (2‐year) follow‐up, 89% of the patients with type 1 and 85% of those with type 2 had an Engel class I outcome, a higher success rate (only 11–15% outside class I) than that observed in other surgical series, although the outcomes were not as good when considering class Ia in both groups (respectively, 66% and 76%), with no significant difference between them. Differences in recruitment, classification, and outcome scales make it difficult to compare these findings with previously published data, but it can be said that they are similar to those of Blumcke et al., de Lanerolle et al., and Savitr Sastri et al., all of which showed that there is no significant short‐term difference in the percentage of class I outcomes between patients with different HS types, and the studies indicating a difference may have been affected by the small number of patients with type 2 …”
Section: Discussionsupporting
confidence: 52%
“…Using the extensive epilepsy surgical literature regarding risk factors of poor surgical outcomes, presumably some from multifocal epilepsy as well as other sources of information such as the relevance of interictal discharges in predicting multifocal epilepsy found in this study allow for a reasonable estimate of a pretest probability. For example, if a patient is found to have unilateral temporal interictal discharges and concordant magnetic resonance imaging (MRI) evidence of hippocampal sclerosis, a reasonable pretest probability of multifocal seizures is 20% . If a patient has bilateral hippocampal changes, the postsurgical data would suggest the estimate would be closer to 50% .…”
Section: Discussionmentioning
confidence: 99%
“…Across patients, HS encompasses a broad spectrum of structural changes, which can be categorized into different subtypes based on neuropathological grading systems [Blumcke et al, ; Blümcke et al, ]. Previous findings have suggested an association between histopathological subtypes, postsurgical seizure outcomes, and postoperative memory impairment [Blümcke et al, ; Savitr Sastri et al, ; Thom et al, ].…”
Section: Introductionmentioning
confidence: 99%